Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Jiangsu Hengrui Pharmaceuticals Co., Ltd.

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co., Ltd. with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Package NDC
0781-3495-95
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.